AdvisorShares Psychedelics ETF
PSIL
#3137
ETF Rang
€18.77 Mio.
Marktkapitalisierung
🇺🇸 US
Markt
15,85 €
Aktienkurs
0.78%
Veränderung (1 Tag)
64.80%
Veränderung (1 Jahr)
Kategorien

AdvisorShares Psychedelics ETF - Bestände

ETF-Bestände zum Stand 16. April 2026Anzahl der Bestände: 23

Vollständige Bestandsliste

Gewichtung %TickerBeschreibungGehaltene Aktien
10.60%
ATAIATAIBECKLEY INC567587
9.46%
RLMDRELMADA THERAPEUTICS INC295872
9.36%
DFTXDefinium Therapeutics, Inc91301
7.50%
CMPSCOMPASS PATHWAYS PLC246739
5.47%
DRUGBRIGHT MINDS BIOSCIENCES INC13513
5.43%
GHRSGH RESEARCH PLC67034
5.24%
ANROALTO NEUROSCIENCE INC44023
5.05%
NRXPNRX PHARMACEUTICALS INC440467
4.91%
HELPCYBIN INC195604
4.45%
ABBVABBVIE INC4665
4.26%
JNJJOHNSON & JOHNSON3978
4.25%
ALKSALKERMES PLC27569
4.20%
NBIXNEUROCRINE BIOSCIENCES INC7170
4.11%
STIMNEURONETICS INC643193
3.92%
SUPNSUPERNUS PHARMACEUTICALS INC17453
3.35%
NEUPNEUPHORIA THERAPEUTICS INC155367
1.87%
KTTAPASITHEA THERAPEUTICS CORP557508
1.86%
QNTMQUANTUM BIOPHARMA-B SUB VOT128591
1.61%
SILOSILO PHARMA INC693965
0.76%
VTGNVISTAGEN THERAPEUTICS INC277110
0.24%
NUMIFNUMINUS WELLNESS INC5359413
0.18%
ENVBENVERIC BIOSCIENCES INC16974
0.03%
CMNDCLEARMIND MEDICINE INC7357